Mold Invasive Fungal Infection: Aspergillus, Mucorales, Fusarium, Scedosporium

1

Review clinical trials related to Mold Invasive Fungal Infection: Aspergillus, Mucorales, Fusarium, Scedosporium. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Immunomonitoring of Mold Invasive Infections

Mold invasive infections are associated with an important mortality despite optimization of the antifungal treatment. In a few case reports, immune checkpoints inhibitors, initially developed for neoplastic diseases, have shown a potential beneficial effect in such devastating infections by restoring an efficient immune response. The investigators propose a longitudinal monitoring of the adaptative immune response, notably immune checkpoint expression on T cells, during mold invasive infections to help identify the patients who could benefit from the adjunction of immunotherapy and the optimal timing of such strategy.

Participants needed: 20
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Assistance Publique - Hôpitaux de ParisUpdated: Nov 20, 2025Locations: 1
Eligibility criteria

Age ≥ 18 years [+7]

Bacterial co-infection in the last 14 days [+1]